In light of the pleiotropic action of hGH, especially in later life, in driving several age-associated comorbidities including cancer, insulin resistance, cardiac hypertrophy, renal insufficiency, and tissue fibrosis, differential antagonism of hGH action is highly promising (23, 75). Here, GH1 is linked to cancer.